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Abstract Green fluorescent protein (GFP) is an attractive
reporter for Salmonella gene expression analysis but might
interfere with virulence when expressed at high levels. To
identify suitable GFP levels, we constructed a series of
Salmonella strains expressing different amounts of GFP and
measured their fluorescence and colonization levels in infected
mice. The results show that GFP concentrations in the range
of 7000^200 000 molecules per Salmonella cell are detectable in
ex vivo samples using flow cytometry, and cause no major
Salmonella virulence defect. Appropriate GFP levels can be
obtained with weak promoters and stable GFP, or strong
promoters and destabilized GFP. ' 2002 Published by Else-
vier Science B.V. on behalf of the Federation of European Bio-
chemical Societies.
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1. Introduction
The green £uorescent protein (GFP) is widely used as a
quantitative reporter for gene expression in diverse organisms.
One interesting application is the analysis of pathogen adap-
tation to host environments during an infection [1]. However,
GFP may pose a metabolic burden on the recombinant patho-
gen and can even be toxic when expressed at high levels [2].
An impaired pathogen may in turn alter its gene expression
pattern so that the analysis technique would a¡ect the vari-
able of interest. For minimal interference, GFP levels should
thus be as low as possible. On the other hand, su⁄cient GFP
is needed for £uorescence detection with an acceptable signal-
to-background ratio. We have recently shown that the spec-
tral separation of GFP emission and tissue auto£uorescence
by two-color £ow cytometry signi¢cantly improves the detec-
tion of GFP-expressing Salmonella cells in infected mouse
tissues [3,4], but the range of in vivo GFP levels that are
both tolerable and detectable is still unknown for Salmonella
and most other pathogens in spite of the numerous infection
studies using GFP constructs.
The GFP concentration depends on its expression rate, its
degradation rate, and the growth rate of the expressing cell
[5]. In this study, we varied both the GFP expression and
degradation rates in a pathogenic Salmonella enterica strain
using di¡erent promoters and well-characterized GFP lifetime
variants, and analyzed the e¡ects on Salmonella growth and
£uorescence detection in infected mice.
2. Materials and methods
2.1. Bacterial strains and plasmids
Salmonella enterica serovar typhimurium SL1344 is a streptomycin-
resistant wild-type isolate [6]. For cloning Escherichia coli ElectroTen-
Blue (Stratagene) was used. Both strains were transformed by electro-
poration and transformants were cultured at 37‡C and 200 rpm in LB
medium supplemented with 100 Wg ml31 ampicillin and 90 Wg ml31
streptomycin (SL1344 transformants), or 100 Wg ml31 ampicillin and
30 Wg ml31 kanamycin (ElectroTen-Blue transformants), respectively.
GFP variants with di¡erent lifetimes in Gram-negative bacteria
(GFP.mut3, lifetime s 24 h; GFP[ASV], lifetime about 110 min;
and GFP[LVA], lifetime about 40 min) [7] were obtained from plas-
mids pJBA27, pJBA113, and pJBA111 generously provided by Dr. S.
Molin, Technical University Lyngby, Denmark. These GFP variants
were expressed from two promoters with di¡erential activity levels in
vivo (PpagC, PspvA ; [8]) by exchanging XbaI/HindIII fragments of plas-
mids pJBA27, pJBA113, and pJBA111 carrying the gfp variants, for
the GFP_OVA fusion genes in pPpagCGFP_OVA or pPspvAGFP_OVA
[8] yielding plasmids pPpagCGFP.mut3, pPpagCGFP[ASV], and
pPpagCGFP[LVA], and plasmids pPspvAGFP.mut3, pPspvAGFP[ASV],
and pPspvAGFP[LVA], respectively. The chromosomal PpagC promoter
drives expression of the putative outer membrane protein PagC that is
required for Salmonella virulence in the mouse model [9]. PspvA on the
Salmonella virulence plasmid drives expression of the spvABCD oper-
on. SpvB can ADP-ribosylate actin thereby inhibiting its polymeriza-
tion in host cells [10]. Both SpvB and SpvC are required for systemic
virulence in the mouse model [11]. For in vitro studies, PpagC was
induced in M9 minimal medium containing 10 WM MgCl2, while
PspvA was induced during overnight growth on agar plates.
2.2. Mice, infection, and £ow cytometry
Female 8^12 weeks old BALB/c mice were obtained from the Bun-
desamt fu«r gesundheitlichen Verbraucherschutz und Veterina«rmedizin,
Berlin, and kept under speci¢c-pathogen-free conditions. For oral in-
fection, Salmonella cultures were grown to the late logarithmic phase
(OD600 1.5; ca. 3U109 CFU ml31) and 100 Wl were orogastrically
administered with a round-tip stainless-steel needle. At 4 days post
infection, mice were sacri¢ced under anesthesia and the Peyer’s
patches were prepared. After homogenization between the sanded
ends of two microscope slides, the suspensions were treated with
0.1% Triton X-100 to liberate intracellular Salmonella cells. Serial
dilutions were plated on streptomycin-containing LB medium with
or without ampicillin to determine colonization levels and plasmid
stability.
For £ow cytometric analysis of Salmonella in vivo GFP expression,
Triton-treated homogenates were ¢xed with 2% formalin and ana-
lyzed with a FACSort £ow cytometer (Becton and Dickinson). Line-
arity and constant ampli¢cation of the £ow cytometer were validated
with intensity calibration beads (Molecular Probes). For suppression
of background auto£uorescence from tissue fragments, both the green
and orange emission channels (FL-1, 515^545 nm; FL-2, 563^607 nm)
were recorded. GFP has an almost 10-fold lower orange/green emis-
sion ratio compared to tissue auto£uorescence which permits the spec-
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tral separation of these two populations with two-color £ow cytome-
try [3,4]. To convert £uorescence measurements to the number of
GFP molecules per Salmonella cell, in vitro cultures of GFP-express-
ing Salmonella cells were analyzed in parallel by £ow cytometry and
SDS^PAGE. Coomassie brilliant blue-stained gels were scanned with
a HP ScanJet 6300C and analyzed using Scion Image software
(PC-version of NIH image, free download at http://www.scioncorp.-
com). After correction for background staining in SL1344 samples,
Salmonella GFP expression was quanti¢ed by comparison with stan-
dards containing 20, 30, 40, and 50 ng of puri¢ed GFP (Clonetech)
and converted into number of GFP molecules per Salmonella cell
which was then used to calibrate the £uorescence measurements.
3. Results and discussion
To determine what GFP levels are compatible with full
Salmonella virulence in a mouse infection model, we con-
structed a series of Salmonella strains that contain di¡erent
GFP concentrations in vivo. In general, the GFP concentra-
tion depends on the expression rate (including transcription,
translation, and maturation), the degradation rate, and the
growth rate which re£ects the dilution due to cell division
[5]. To modulate the GFP expression rate, we used the strong
PpagC promoter or the weak PspvA promoter [8]. To modulate
the GFP degradation rate, we compared stable GFP.mut3 [12]
to two well-characterized destabilized GFP variants
(GFP[ASV] and GFP[LVA]) that contain C-terminal recogni-
tion sequences for the tail-speci¢c protease [7].
3.1. In vitro characterization
During in vitro growth under inducing conditions, all
constructs containing PpagC upstream of GFP are highly
£uorescent with intensities in the order GFP.mut3W
GFP[ASV]sGFP[LVA] (Fig. 1A) in agreement with previous
data for these GFP variants in E. coli [5,7]. All three recombi-
nant Salmonella strains have similar in vitro division times
(pPpagCGFP.mut3, 37S 5 min; pPpagCGFP[ASV], 35S 5 min;
pPpagCGFP[LVA], 38S 5 min) compared to wild-type SL1344
(33S 5 min) suggesting that at the tested concentrations, GFP
expression is well tolerated in vitro. In contrast to the PpagC
constructs, only small subpopulations of Salmonella cells in
which PspvA drives GFP expression exhibit detectable £uores-
cence suggesting that our in vitro induction conditions for this
promoter (stationary growth phase on agar plates) are sub-
optimal. Again, the £uorescence intensity of expressing cells is
in the order of GFP.mut3sGFP[ASV]sGFP[LVA] (data
not shown).
To determine if the intrinsic brightness of the various
GFP variants is comparable, SL1344(pPpagCGFP.mut3),
SL1344(pPpagCGFP[ASV]), and SL1344(pPpagCGFP[LVA])
cultures were analyzed by SDS^PAGE (Fig. 1B). Samples
that were normalized for equal £uorescence intensity as deter-
mined by £ow cytometry contained similar amounts of
GFP suggesting that the di¡erent GFP variants have a com-
parable £uorescence quantum yield. De¢ned amounts of pu-
ri¢ed GFP were used as standards to estimate that 106
SL1344(pPpagCGFP.mut3) cells contain 20S 5 ng GFP (aver-
age of two independent measurements). Based on the molec-
ular mass of GFP of 26 900 g mol31 and the Avogadro num-
ber of 6.023U1023 molecules mol31, this corresponds to
0.74S 0.2 fmol or 4.4 S 1U1011 molecules in 106 bacteria
which is equivalent to 440 000S100 000 copies per cell. We
combined this result with £ow cytometric data of the same
cultures to calibrate the GFP £uorescence units. Some GFP
variants form non-£uorescent inclusion bodies when expressed
to high levels which would result in an underestimation of the
Fig. 1. In vitro characterization of GFP-expressing Salmonella strains. A: GFP expression in induced in vitro cultures of
SL1344(pPpagCGFP.mut3) (thick line), SL1344(pPpagCGFP[ASV]) (dotted line), and SL1344(pPpagCGFP[LVA]) (shaded). The £uorescence inten-
sity is given in GFP equivalents (see text for explanation). Plasmid-free SL1344 cells have no detectable £uorescence in the range shown.
B: SDS^PAGE of the same cultures as shown in (A). To normalize for equal £uorescence intensities, di¡erent cell numbers were applied (lane
2: SL1344(pPpagCGFP.mut3), 2.4U106 CFU; lane 3: SL1344(pPpagCGFP[ASV]), 2.7U106 CFU; lane 4: SL1344(pPpagGFP[LVA]), 4.1U106
CFU). The solid arrowhead indicates the apparent molecular weight of GFP.mut3, the open arrowhead indicates the apparent molecular
weights of GFP[ASV] and GFP[LVA] that are larger due to the fused C-terminal recognition sequences of the tail-speci¢c protease [7]. For
comparison, 2.4U106 CFU plasmid-free SL1344 (lane 1), and puri¢ed GFP (lane 5: 50 ng, lane 6: 25 ng) were also applied.
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actual GFP concentrations by £uorescence measurements. In
our Salmonella in vitro cultures, no insoluble GFP.mut3 could
be detected SDS^PAGE of fractionated lysates even at expres-
sion levels exceeding 1 000 000 copies per cell (our unpublished
data) in agreement with previous data for this GFP variant
[12]. For most constructs, in vivo and in vitro £uorescence
levels are similar (see below) suggesting that in vivo also little
if any GFP inclusion bodies are formed.
3.2. In vivo characterization
To characterize the in vivo properties of the various con-
structs, BALB/c mice were orally infected with either strain
and 4 days later, Peyer’s patches were prepared, homogenized,
and analyzed using two-color £ow cytometry. All three con-
structs containing the PpagC promoter have detectable in vivo
levels of GFP in the order GFP.mut3EGFP[ASV]sGFP-
[LVA] (Fig. 2). The in vivo levels of GFP[ASV] and
GFP[LVA] are similar to induced in vitro levels (see Fig.
1A), while the GFP.mut3 construct contains in vivo some
¢ve-fold more GFP compared to in vitro conditions. The
only PspvA construct with detectable in vivo GFP levels con-
tains GFP.mut3. This construct requires two-color £ow cyto-
metry to distinguish GFP-expressing bacteria from auto£uor-
escent tissue fragments (see Section 2) while all PpagC
constructs are bright enough for conventional one-color mea-
surements (Fig. 2).
High in vivo GFP levels could pose a metabolic burden on
Salmonella cells that may interfere with their ability to adapt
to the hostile host environments. This could result in plasmid
instability and/or lower colonization levels both of which are
undesirable for gene expression studies. To test this hypoth-
esis, tissue homogenates from infected mice were replica
plated on media with or without ampicillin. While all con-
structs stably maintain their plasmids (s 90% in all cases),
SL1344(pPPagCGFP.mut3) had colonization levels at 4 days
post infection that are several orders of magnitude lower
than those of plasmid-free SL1344 (Fig. 2) suggesting that
the rather high GFP levels in these Salmonella cells indeed
impair their in vivo growth. While SL1344(pPpagCGFP[ASV])
is also signi¢cantly impaired, SL1344(pPpagCGFP[LVA])
reached colonization levels comparable to those of plasmid-
free SL1344. As the three PpagC constructs di¡er solely in the
GFP degradation rate, this result suggests that Salmonella
virulence is impaired by a high steady state GFP concentra-
tion but less a¡ected by strong gfp transcription and trans-
lation, or plasmid maintenance.
The large di¡erences in both colonization levels and in vivo
GFP concentrations between SL1344(pPPagCGFP.mut3) and
SL1344(pPpagCGFP[ASV]) are surprising based on their very
similar in vitro behavior (Fig. 1). Interestingly, we made sim-
ilar observations when we compared stable GFP.mut2 [12]
with its degradable variant GFP_OVA [8] expressed from
the identical promoter. Both variants are similarly abundant
in exponential Salmonella in vitro cultures but in vivo,
GFP.mut2 levels are up to 20-fold higher compared to
GFP_OVA levels (our unpublished data). During fast in vitro
growth (division times around 35 min, see above), GFP dilu-
tion due to cell division may be the dominating mechanism of
GFP concentration loss while GFP degradation may be less
important [5]. Hence, subtle di¡erences in the degradation
rates of stable GFP.mut3 vs. slowly degradable GFP[ASV]
(or stable GFP.mut2 vs. degradable GFP_OVA) might not
translate into a large GFP concentration di¡erence. In con-
trast, Salmonella growth in vivo is much slower with division
times in the range of 170^300 min [13] possibly resulting in
more obvious e¡ects of the di¡erent lifetimes of GFP.mut3
and GFP[ASV] [5]. The high GFP concentration in
SL1344(pPPagCGFP.mut3) apparently results in an even slow-
er in vivo growth, which in turn further increases the GFP
concentration, as GFP is less diluted by cell division.
All tested PspvA constructs including SL1344-
(pPspvAGFP.mut3) colonize well (Fig. 2) indicating that stable
GFP.mut3 can be successfully used when expressed from a
weak promoter instead of the strong PpagC. This further sup-
ports that the GFP concentration is critical for virulence while
unrelated intrinsic properties of the various GFP variants
seem to be less relevant.
3.3. Conclusion
GFP is an attractive reporter for gene expression of patho-
gens in infected hosts. However, it has been unclear if GFP
levels that are high enough for detection are compatible with
an unimpaired virulence of the pathogen. Here we show that
GFP levels below ca. 200 000 molecules per Salmonella cell are
well tolerated in vivo. Such levels are high enough for conven-
tional one-color detection even in infected tissue samples with
high background auto£uorescence (Fig. 2). For lower expres-
sion levels, background suppression by two-color £ow cyto-
metry is preferable as it decreases the detection threshold from
about 100 000 to about 7000 molecules per cell. This value is
still rather high compared to Salmonella in vitro cultures in
which GFP levels down to 500 molecules per cell can be
detected (our unpublished data).
Fig. 2. GFP content and colonization levels of various Salmonella
strains in murine Peyer’s patches at 4 days post infection: PpagC
constructs (solid), PspvA constructs (open), GFP.mut3 (circle),
GFP[ASV] (down triangle), GFP[LVA] (up triangle). The cross rep-
resents plasmid-free SL1344. For each construct, the median £uores-
cence intensity and 25 and 75 percentiles were plotted against the
mean CFU and the standard error of the mean of six mice from
two independent experiments. Statistical di¡erences to SL1344 colo-
nization levels were tested using the t-test (*P6 0.05; **P6 0.01).
The detection range for GFP-expression in infected mouse tissues
using one-color (black bar) or two-color £ow cytometry (gray bar)
are also shown; b.t. below detection threshold.
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To obtain in vivo GFP levels in the suitable range between
7000 and 200 000 molecules per cell with weak promoters, one
may use stable GFP variants expressed from plasmids with
medium copy number such as pPspvAGFP.mut3. High copy
number plasmids would yield even more GFP but such plas-
mids interfere with Salmonella virulence [14]. On the other
hand, strong promoters are best studied with unstable GFP
variants such as GFP[LVA]. As an additional advantage, the
short lifetimes of unstable variants (minutes to hours instead
of s 1 day for GFP.mut3 [5,7]) allow to resolve downregula-
tion that is di⁄cult to detect with stable GFP. Alternative
approaches to decrease GFP concentration such as unfavor-
able ribosomal binding sites, or chromosomal integration of
the expression cassette to lower the gene copy number are also
suitable for experiments involving strong promoters.
In summary, the combination of GFP lifetime variants
with two-color £ow cytometry allows to characterize Salmo-
nella promoters with a wide range of activities during infec-
tion.
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